| P50 | author | Hans-Peter Kiem | Q88408730 |
| | Jacob D Estes | Q90263659 |
| | Claire Deleage | Q90797291 |
| | Shiu-Lok Hu | Q56933191 |
| | Keith R. Jerome | Q57904630 |
| | Meei-Li Huang | Q61713476 |
| P2093 | author name string | Jasbir Kaur | |
| | Michael C Holmes | |
| | Jianbin Wang | |
| | Andreas Reik | |
| | Patricia Polacino | |
| | Christopher W Peterson | |
| | Sowmya Reddy | |
| P2860 | cites work | Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele | Q22066229 |
| | Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation | Q26749553 |
| | CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape | Q26801498 |
| | The Dynamics of T and B Cells in Lymph Node during Chronic HIV Infection: TFH and HIV, Unhappy Dance Partners? | Q28067520 |
| | Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives | Q28075204 |
| | Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV | Q28235281 |
| | Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells | Q28237048 |
| | Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation | Q28300338 |
| | Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection | Q28478654 |
| | Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV | Q28551642 |
| | Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation | Q29615068 |
| | Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases | Q34539993 |
| | B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers | Q35058635 |
| | Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption | Q35190018 |
| | Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation | Q35588845 |
| | Pharmacokinetics of antiretrovirals in mucosal tissue | Q35838594 |
| | Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation | Q36067042 |
| | Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells | Q36266486 |
| | Global properties of nested network model with application to multi-epitope HIV/CTL dynamics | Q36285847 |
| | Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging study | Q36350457 |
| | Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses | Q36424574 |
| | Persistent Simian Immunodeficiency Virus Infection Drives Differentiation, Aberrant Accumulation, and Latent Infection of Germinal Center Follicular T Helper Cells | Q36481555 |
| | Hematopoietic stem cell transplantation for HIV cure | Q36515124 |
| | HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells | Q36757040 |
| | Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation | Q36796554 |
| | Persistent HIV-1 replication maintains the tissue reservoir during therapy | Q36897321 |
| | Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates | Q36920437 |
| | Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model. | Q37006885 |
| | Defining HIV and SIV Reservoirs in Lymphoid Tissues. | Q37090999 |
| | Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection | Q37169285 |
| | HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads. | Q37300347 |
| | HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer. | Q37300442 |
| | Where does HIV hide? A focus on the central nervous system | Q37590425 |
| | Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption | Q37624842 |
| | The majority of CD4+ T-cell depletion during acute simian-human immunodeficiency virus SHIV89.6P infection occurs in uninfected cells | Q37643739 |
| | Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation | Q37661792 |
| | Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effect | Q38057359 |
| | Is the CCR5 Δ 32 mutation associated with immune system-related diseases? | Q38068379 |
| | Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect | Q39059436 |
| | Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells | Q40351372 |
| | Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy | Q40411834 |
| | Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides | Q42148874 |
| | The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. | Q43521980 |
| | Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis | Q44477645 |
| | Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge | Q45401399 |
| | Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer | Q48881552 |
| | The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin. | Q50582759 |
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 4 | |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | e1006956 | |
| P577 | publication date | 2018-04-19 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy | |
| P478 | volume | 14 | |